IN8bio director receives option grant for 22,000 shares
IN8BIO director Greenwood Luba received a stock option grant for 22,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IN8BIO director Greenwood Luba received a stock option grant for 22,000 shares of common stock. The option has an exercise price of $1.58 per share and expires on May 9, 2036. One-twelfth of the shares vest monthly starting June 9, 2026, with full vesting at the next annual stockholders’ meeting if service continues.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 22,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 9, 2026; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.
Key Figures
Key Terms
Stock Option (right to buy) financial
exercise price financial
vesting financial
expiration date financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IN8BIO (INAB) director Greenwood Luba report?
What is the exercise price of Greenwood Luba’s IN8BIO stock options?
How do Greenwood Luba’s IN8BIO stock options vest?
When do Greenwood Luba’s IN8BIO stock options expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.